TheWell Bioscience Launches A New Generation of Bioinks for 3D Bioprinting Requiring No UV, No Temperature/pH Curing or Chemical Crosslinking

North Brunswick, NJ – January 13, 2020 – TheWell Bioscience Inc, a biotech company focusing on 3D cell culture, launches VitroINK™, a new series of xeno-free tunable bioink system that requires no UV, no temperature/pH curing or chemical crosslinking. The new bioinks are ready-to-use at room temperature, have excellent visibility after printing, and can incorporate multiple bio-functional ligands for different applications.

3D bioprinting is an emerging technology to construct complex and physiologically relevant multicellular tissue or disease models for regenerative medicine and drug discovery.Despite its significant potential, there are tremendous challenges in cytocompatibility, printability, and adjustable mechanical properties of current bioinks for 3D scaffold fabrication and long-term cell culture. Also, the crossing methods of current bioinks rely on temperature adjustment, chemical reactions, or UV curing, which would cause cell damage during the process.

The new VitroINK system can solve these issues. Due to the unique shear-thinning and rapid recovery mechanical property, VitroINK can well maintain the printed structure after extrusion without UV or other special curing methods. Simply adding the cell culture medium after printing can further stabilize the printed structure and support cell growth.

“Scientists currently using our VitroGel hydrogel like the ready-to-use and tunability of the products.We keep receiving requests to transfer the same features to a bioink product. Although, the current injectable VitroGel system can cover the elastic modulus range from 10 to 5000 Pa for soft bioprinting,” said John Huang, CEO and founder of TheWell Bioscience. “To get a higher 3D scaffold structure, a stronger hydrogel is needed. VitroINK was developed to reach a high mechanical strength that is close to GelMA for structure printing.”

With the biocompatible features and the capabilities of biofunctional modifications,VitroINK will be a powerful tool to advance3D bioprinting for research and pharmaceutical applications. VitroINK is compatible with many popular bioprinters in the market.


TheWell Bioscience provides research enabling products and services for 3D cell culture, drug screening, and tissue engineering for pre-clinical applications. The company also uses its advanced biomaterial as an injectable carrier to improve cell therapy and drug delivery.

To learn more about our product lines and research services, visit:

Media Contact
Company Name: TheWell Bioscience Inc.
Contact Person: Neer Hirpara
Email: Send Email
Phone: 9738554955
Address:675 US HIGHWAY 1
City: North Brunswick
State: NJ
Country: United States